The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.
NYS Entity Status
NYS Filing Date
APRIL 01, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - J'EAT JET BAR INC.
AROUND THE WEB
- Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
By LIAM STACK - Monday Jun 19, 2017
- Neighborhood Joint: Staubitz Market in Brooklyn: 100 Years of Sawdust, Steaks and Chops
By ANDREW COTTO - Wednesday Jun 14, 2017
A display contains frozen items, and the shelves are stocked with jars and cans. But there’s just one reason to visit this Boerum Hill business: meat.
- In the Huddle With NY Jets Owner Woody Johnson
Friday Oct 15, 2010
Woody Johnson, owner of the New York Jets NFL franchise, joins WSJ's Lee Hawkins for the "WSJ Weekend Conversations" series to talk about the Jets' Super Bowl prospects, co-chairing the 2014 Super Bowl host committee, and his charitable interests.
- Cyclist Killed by Bus in New York’s First Citi Bike Fatality
By MATTHEW HAAG and HANNAH ALANI - Tuesday Jun 13, 2017
Dan Hanegby of Brooklyn fell under a bus’s tires in Chelsea. He worked for Credit Suisse and was once the top-ranked tennis player in Israel.
- Walmart to Buy Bonobos, Men’s Wear Company, for $310 Million
By MICHAEL J. de la MERCED - Friday Jun 16, 2017
Acquiring the clothing brand born on the internet is intended to energize Walmart’s e-commerce strategy as it races to catch up with Amazon.
- Stonewall Inn Project to Preserve Stories Behind a Gay Rights Monument
By SARAH MASLIN NIR - Saturday Jun 17, 2017
A $1 million grant will go toward conserving the oral histories of those who lived through the 1969 riots.
- We Taste-Tested 10 Hot Dogs. Here Are the Best.
By JULIA MOSKIN - Tuesday Jun 27, 2017
Sam Sifton, Melissa Clark and Julia Moskin tried 10 hot dogs for cookout season.
- Insurers Battle Families Over Costly Drug for Fatal Disease
By KATIE THOMAS - Thursday Jun 22, 2017
The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.